ArticleERJ open research2025
Healthcare resource utilisation in patients with exacerbations of COPD and associated cardiovascular events: the EXACOS-CV study.
Article in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The patient-level economic burden of COPD in China: a systematic review of determinants and consequences.Frontiers in public health · 2026Pooled it
- Correlation between anemia-related red blood cell parameters and pulmonary function severity in patients with AECOPD.Frontiers in medicine · 2026Article
- Association of Cardiovascular Disease and Its Subtypes with Prognosis in Hospitalized Patients with AECOPD: A Retrospective Cohort Study.International journal of chronic obstructive pulmonary disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The EXACOS-CV Canada study described and evaluated treatment patterns, healthcare resource utilisation (HCRU), and costs in patients with COPD who experienced a severe cardiovascular (CV) event or death preceded or not preceded by an exacerbation. Methods: This longitudinal, retrospective cohort study included 142 787 individuals with COPD using administrative data from Alberta, Canada. The index event was a first hospitalisation for a CV event or all-cause death during follow-up. COPD-related treatment, HCRU and costs during the 12-month periods before and after the index events were described. Results: From the initial cohort, 43 564 (30.5%) patients with COPD experienced an index event; 15 100 (34.7%) had a COPD exacerbation in the 12 months prior. Patients whose index event was preceded ( Discussion: Patients whose index events were preceded
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.